1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow COL: new trials by email Literature Review of COL trials Research Report on COL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia | Phase 3 | Completed | Pfizer | 422 | 2018-04-05 | 2024-12-10 |
Pneumonia, Ventilator-Associated (1)
Pfizer (1)
Argentina (1) · Bulgaria (1) · China (1) · Croatia (1) · Czechia (1) · Greece (1) · India (1) · Israel (1) · Italy (1) · Malaysia (1) · Mexico (1) · Philippines (1) · Romania (1) · Russia (1) · South Korea (1)
PMID 38252170, PMID 39389071, PMID 40530972, PMID 41269522
2017 (1)